Taurine for Sleep Onset Difficulty
B Good Evidence At least one randomized trial supports this, with mostly consistent results.Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003Dtaurine\u0026condition\u003Dsleep\u002Donset\u002Dlatency';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
The Bottom Line
Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
Key Study Findings
Controlled Clinical Trial
n=32
12 weeks
Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None
vs: Standard care alone
Outcome: Itch and insomnia improvement in atopic dermatitis
Effect: None
0.0449 (itch), 0.0089 (insomni
Population: Patients with atopic dermatitis and mild-moderate negative emotions
Other
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Dose: None
vs: None
Outcome: None
Effect: None
p < .05
Population: Insomnia patients
Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None
vs: None
Outcome: Pain outcomes
Effect: None
None
Population: Insomnia patients
Observational Study
[Energy drink consumption patterns and its adverse effects on adolescent health.].
Dose: None
vs: None
Outcome: Energy drink consumption and adverse effects
Effect: None
None
Population: Adolescents
Other
[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …
Dose: None
vs: None
Outcome: rat model of cardiorenal insomnia from in vitro …
Effect: None
None
Population: None
Review
Assessment and treatment of insomnia in adult patients with alcohol use disorders.
Dose: None
vs: None
Outcome: None
Effect: None
None
Population: insomnia patients
Key Statistics
9
Studies
32
Participants
↔
Mixed
B
Grade
Referenced Papers
Asian Pacific journal …
2025
6 citations
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Other
PloS one
2024
5 citations
Frontiers in medicine
2024
4 citations
Revista espanola de …
2022
2 citations
Zhongguo Zhong yao …
2020
5 citations
Alcohol (Fayetteville, N.Y.)
2015
122 citations
British journal of …
2014
111 citations
Alcohol and alcoholism …
2011
40 citations
Journal of the …
2008
300 citations
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- sleep:
- 500-2,000 mg, 1 hour before bed
Upper limit: 3,000 mg/day considered safe in clinical studies
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | 12 weeks | Positive | 32 |
| None | -- | Neutral | -- |
| None | -- | Neutral | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
Best taken: 1 hour before bed
Safety & Side Effects
Reported Side Effects
- ⚠ Generally well tolerated
- ⚠ Mild GI discomfort at high doses
- ⚠ Drowsiness (desired for sleep use)
Known Interactions
- ● Lithium — taurine may alter lithium excretion
- ● Antihypertensives — may have additive blood pressure lowering effects
- ● CNS depressants — potential additive sedative effects
Tolerable upper intake: 3,000 mg/day considered safe in clinical studies
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Taurine help with Sleep Onset Difficulty?
Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support Sleep Onset Difficulty management. Our evidence grade is B (Good Evidence).
How much Taurine should I take for Sleep Onset Difficulty?
Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Taurine?
Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Taurine and Sleep Onset Difficulty?
We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.
Related Evidence
Other ingredients for Sleep Onset Difficulty
Taurine for other conditions
References
- [1] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
- [2] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
- [3] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
- [4] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
- [5] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
- [6] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
- [7] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
- [8] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
- [9] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.